Earnings Feed
Start Free
Processa Pharmaceuticals, Inc.·4/A

Feb 18, 5:57 PM ET

Young David 4/A

4/A · Processa Pharmaceuticals, Inc. · Filed Feb 18, 2025

Insider Transaction Report

Form 4/AAmended
Period: 2025-01-27
Processa Pharmaceuticals, Inc.PCSA
Young David
DirectorPres. Research & Development
Transactions
  • Award

    Warrants

    2025-01-29+124,500→ 124,500 total
    Exercise: $0.65From: 2025-01-29Exp: 2030-01-29→ Common Stock (124,500 underlying)
  • Award

    Warrants

    2025-01-29+62,250→ 62,250 total
    Exercise: $0.65From: 2025-01-29Exp: 2030-01-29→ Common Stock (62,250 underlying)
Holdings

  • Common Stock

    (indirect: By Family Entities)
    10,786

  • Common Stock

    205,405

  • Common Stock

    (indirect: By Trust)
    30,985

  • Common Stock

    (indirect: By LLC)
    18,544

Documents

1 file
  • 4
    form4.xml